Compared with its expression in healthy tissues, ASCT2 is overexpressed in many tumours, such as non-small cell lung cancer (NSCLC) [4], breast cancer [5], and hepatocellular carcinoma [6]. This evidence concerns the gene SLC1A5 and neoplasm.